European research project iPC has started

KiTZ scientists Stefan Pfister and Natalie Jäger participate in the consortium.

iPC scientists
Scientists from eleven countries joined to fight against children’s cancer. © iPC Coordination

The European research project iPC (individualized Pediatric Cure) has started. It is about investigating the possibilities of individual treatment combinations in childhood cancer in order to maximize treatment success and minimize side effects.

In the next four years, 21 partners from eleven different countries, including nine European Union Member States (Austria, Belgium, Switzerland, Germany, Spain, France, Italy, Netherlands, Slovenia), along with the USA and Australia will work together. The KiTZ scientists Stefan Pfister and Natalie Jäger are also involved as researchers and advisors to the consortium.

The project team will focus on identifying effective personalized medicine for paediatric cancers and will address a multitude of challenges. To  meet  these  challenges,  a  comprehensive  computational  effort  to combine  knowledge-base,  machine-learning,  and  mechanistic  models  to predict  optimal  standard  and experimental therapies for each child will be proposed. The goal of the iPC project is to collect, standardize and harmonize existing clinical knowledge and medical data  and, with  the  help  of  artificial  intelligence,  create  treatment  models  for each patient. Armed with these treatment models, scientists will then test them on virtual patients to evaluate treatment efficacy and toxicity, thus improving both patient survival and their quality of life.

The iPC project has received 15 million euros funding from the European Union’s Horizon 2020 research and innovation programme.

ICP press release:

More about the iPC-project:

More about the EU Research and Innovation programme „Horizon2020“: